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The evidence that patients with heart failure (HF) experience cog-
nitive impairment is compelling.1 Cognitive impairment occurs in
one- to three-quarters of HF patients2 and leads to poor health
outcomes including reduced activities of daily living,3 inadequate
engagement in HF self-care,2 clinical instability,4 and premature
death.5 The escalating number of research papers investigating cog-
nitive impairment in HF patients attests to the significance of this
co-morbidity.1–5 Even so, inconsistencies in the operationalization
of cognitive impairment are widespread, resulting in a variety of
screening methods6 and conflicting estimates of its severity and
prevalence in HF populations.7 This point is highlighted by four
studies published in the past 2 years in this journal, whereby cog-
nitive impairment has been assessed with: brief screening ques-
tionnaires of global cognitive functioning;8,9 a more comprehensive
screening recognized to diagnose mild cognitive impairment and
primary degenerative dementia;10 and a battery of neuropsycholog-
ical tests, that included a global cognitive screening questionnaire.11
It is acknowledged that HF patients typically exhibit cognitive
impairment in domains of memory (working and delayed recall),
attention, processing speed, and executive function;12 yet, to date,
studies have been limited by use of only screening questionnaires
rather than a gold standard neuropsychological battery of tests.
This is reflected in two studies published recently in this journal.
In the TIME-CHF study,8 cognitive impairment was classified as
severe if HF patients scored ≤7 on the Hodkinson Abbreviated
Mental Test. This screening questionnaire has been used in general
ageing populations to screen for dementia. From the 611 patients
enrolled in the study, 56 (9%) were classified with severe cognitive
impairment on the basis of the screening questionnaire, with
no other neuropsychological assessment.8 Likewise, Davis and
colleagues9 had used the classification of mild cognitive impairment
as the study inclusion criterion for a cognitive training intervention
aimed at improving self-care behaviours. The Montreal Cognitive
Assessment had been applied, and only HF patients who had scored
between 17 and 25 were invited to participate in the study. Once
again, no other neuropsychological assessment had been used to
characterize cognitive impairment among the 125 HF patients who
participated in the study.9
*Corresponding author. Cardiovascular Research Centre, Australian Catholic University, VECCI Building Level 4, 486 Albert Street, Melbourne, VIC 3002, Australia. Tel: +61 3
9953 3698, Fax: +61 3 9662 1857, Email: Jan.Cameron@acu.edu.au
The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology.
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
. In the instances when neuropsychological tests have been admin-
istered, comparison data between HF patients and appropriate
age- and education-matched control groups have not always been
employed, and cognitive impairment has not been specified as being
within the seventh percentile (>1.5 SD) below normative data.11
In a study to determine whether HF patients experience greater
loss in grey brain matter than patients with ischaemic heart disease
whowere HF free,10 temporal changes in cognition were compared
using the Cambridge Cognitive Examination of the Elderly Revised
(CAMCOG). No specified cut-off score on the CAMCOG had
been used to characterize the presence, or absence, of cognitive
impairment and, over time, the cognitive functioning of HF patients
did not differ significantly from that of the control groups. Con-
versely, Hjelm and colleagues11 examined cognitive impairment of
137 HF patients with and without sleep-disordered breathing. Cog-
nitive impairment was assessed using the Mini-Mental State Exam-
ination (MMSE) and the administration of a battery of neuropsy-
chological tests to assess psychomotor speed, visual–spatial per-
ception, and memory. These cognitive domains are often impaired
in HF.5 According to the cognitive assessment using the MMSE,11
18% were characterized as having mild cognitive impairment and
4% potentially suffered dementia. However, it is difficult to draw
any firm conclusion of cognitive impairment from the neuropsycho-
logical battery assessment, as the performance of HF patients had
not been compared with published norms or a healthy control. The
discrepancies among these studies highlight the variations that have
been used to screen and characterize cognitive impairment in HF
patients, and imply the need for consensus guidelines in screening
for this. However, in order to reach consensus on cognitive screen-
ing practices for HF patients, two fundamental questions need to
be addressed: ‘when (to screen)?’, and ‘what [questionnaire(s)] to
use?’.
The most widely used cognitive screening questionnaire, the
MMSE,13 has been brought into question regarding its diagnostic
accuracy (sensitivity and specificity) for screening for mild cognitive
impairment in general14 and in HF populations.15 Of note, the
MMSE is now licensed, and the cost of purchase may be prohibitive
to many HF management programmes. Additionally, several other
© 2013 The Authors
European Journal of Heart Failure © 2013 European Society of Cardiology
236 Editorial
screening questionnaires are publicly available that have satisfactory
sensitivity and specificity for determining, or ruling out, mild
cognitive impairment in other population groups.14,16 A recent
systematic review of cognitive screening questionnaires utilized
in HF studies6 concluded that the veracity of these measures
in accurately screening for both mild cognitive impairment and
more severe impairments in HF populations is questionable, and
appropriate thresholds need to be established.
In addition to issues of sensitivity and specificity, ethical issues in
cognitive screening of HF patients need to be considered.Weighing
of potential benefit vs. risk, or harm, is essential when assessing
the value of patient screening. Potential risks from screening for
any disease or disorder include false negatives that consequently
delay treatment, or false positives that may result in inappropriate
labelling, with potential psychological manifestations and adverse
legal and economic outcomes.17 Social and fiscal ramifications for
HF patients may extend to a loss of their driver’s licence or full
employment, and an increase in their health insurance premiums.
On the basis of a cognitive screening score, which indicates the
need for further evaluation, careful consideration should be given
when referring patients for a formal neuropsychological assessment
as this can impose a substantial burden on HF patients already sleep
deprived,11 not to mention an already overburdened healthcare
system. Ultimately, the value of screening for cognitive impairment
in HF patients should be determined by its effect on morbidity,
mortality, and disability.18
Mild cognitive impairment, a syndrome defined by a set of clin-
ical, cognitive, and functional criteria,19 also has serious adverse
outcomes, including progression to dementia and death.20 Impor-
tantly, consensus on the conceptualization and diagnostic criteria
of mild cognitive impairment (that does not meet the severity for
Alzheimer’s disease or other dementias) was recently achieved as:
concern regarding a change in cognition; impairment in one or
more cognitive domains; preservation of independence in func-
tional abilities; and absence of dementia.19 The immediate prac-
tical implications of gaining consensus will lead to improvements in
screening practice, diagnosis, and management of cognitive impair-
ment among HF populations.
Research is only just emerging in regard to interventions such
as cognitive training strategies to identify whether the impair-
ment exhibited by HF patients is amenable to interventions.21
Currently, there is insufficient evidence to develop recommen-
dations for strategies that improve cognitive impairment for HF
patients. Nonetheless, cognitive training strategies are an emerg-
ing science in the ageing and psychology field.22 Many lessons
could be learnt through establishing an interdisciplinary approach
to research addressing this fundamental aspect of the management
of cognitive impairment in HF patients.
There is compelling evidence that HF patients are vulnerable
to cognitive impairment, which has serious consequences for
patient outcomes and healthcare resources. It is imperative that
cognitive screening measures administered to HF patients be
psychometrically evaluated.6 Such an approach could include the
administration of two or three screening questionnaires and a
neuropsychological battery of tests, to both HF patients and age-
and education-matched control individuals. In this manner, the ..
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.. diagnostic test accuracy of the cognitive screening questionnaire
could be examined. With up and coming research investigating
strategies directed at improving the cognitive functioning of HF
patients, the evidence on which cognitive measures to use and
when best to screen is far overdue. It is now time to inform clinical
practice guidelines on how and when cognitive screening should be
undertaken.
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